Skip to main content
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
Tena Rosser
Sign up to set email alerts
125
Publications
2,675
Citation Statements Received
4,609
Citation Statements Given
How they've been cited
3,556
98
2,552
25
How they cite others
3,848
169
4,432
8
Affiliations
Children's Hospital of Los Angeles
,
University of Southern California
Publications
Order By: Most citations
Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation
Legius
1
,
Messiaen
2
,
Wolkenstein
3
et al.
2021
Genetics in Medicine
Abstract
Show
867
7
514
0
Get access via publisher
Add to collection
Cite
Autism traits in the RASopathies
Adviento
1
,
Corbin
2
,
Widjaja
3
et al.
2013
J Med Genet
Abstract
Show
189
13
202
3
Get access via publisher
Add to collection
Cite
Mutations in DARS Cause Hypomyelination with Brain Stem and Spinal Cord Involvement and Leg Spasticity
Taft
1
,
Vanderver
2
,
Leventer
3
et al.
2013
The American Journal of Human Genetics
Abstract
Show
189
3
194
1
Get access via publisher
Add to collection
Cite
Cerebrovascular abnormalities in a population of children with neurofibromatosis type 1
Rosser
1
,
Vézina
2
,
Packer
3
2005
Neurology
Abstract
Show
275
12
179
4
Get access via publisher
Add to collection
Cite
Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation
Plotkin
1
,
Messiaen
2
,
Legius
3
et al.
2022
Genetics in Medicine
315
2
188
0
Get access via publisher
Add to collection
Cite
Multicenter, Prospective, Phase II and Biomarker Study of High-Dose Bevacizumab as Induction Therapy in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannoma
Plotkin
1
,
Duda
2
,
Muzikansky
3
et al.
2019
JCO
Abstract
Show
133
5
122
1
3
Get access via publisher
Add to collection
Cite
Alterations in White Matter Microstructure in Neurofibromatosis-1
Karlsgodt
1
,
Rosser
2
,
Lutkenhoff
3
et al.
2012
PLoS ONE
Abstract
Show
90
9
106
4
Get access via publisher
Add to collection
Cite
The Use of MEK Inhibitors in Neurofibromatosis Type 1–Associated Tumors and Management of Toxicities
Klesse
1
,
Jordan
2
,
Radtke
3
et al.
2020
Abstract
Show
116
0
103
0
Get access via publisher
Add to collection
Cite
1
2
3
4